Selbyville, Delaware, Oct. 22, 2020 (GLOBE NEWSWIRE) — According to industry experts, global cell line development market accounted for USD 4.21 billion in the year 2019 and is projected to register a robust CAGR of 13.40% during 2020-2027. Extensive application in diagnostics, bioproduction, and research, alongside rising investments towards research & development activities, and escalating demand for monoclonal antibodies as well as biosimilars are augmenting the growth of the market.
The emergence of the COVID-19 pandemic has plummeted the global economy, severely impacting production and demand across numerous verticals, and disrupting the supply chain. Holistic industry analysis aims to answer all the client queries and suggests business tactics employed by leading players to adapt to upcoming uncertainties. Additionally, it also offers a deep-dive investigation of key participants of the market, inclusive of their production capabilities, product offerings, and manufacturing facilities.
For the uninitiated, cell line is a cell culture process in which cells are multiplied under controlled space and medium. It allows systematic alterations in the structure, physiology, and genetic makeup of the cells and has widespread applications in drug research & development activities as well as in studying the effect of toxic compounds.
Request Sample copy of this Report @ https://www.marketstudyreport.com/request-a-sample/2956010/
Additionally, rising prevalence of autoimmune diseases and cancers have impelled the demand for cost-efficient and accurate treatments, which along with increasing production of vaccines is stimulating global cell line development market outlook. However, high capital investments associated with the process are expected to hamper the market expansion throughout the analysis timeframe.
Based on product terrain, global cell line development industry is fragmented into reagents, media, and equipment. With regards to cell line type, the market is divided into primary cell lines, hybridomas, continuous cell lines, and recombinant cell lines. The application spectrum of the industry comprises of drug discovery, research, toxicity testing, tissue engineering & regenerative medicine, and bioproduction.
From regional frame of reference, North America accounts for a majority stake of global cell line development market valuation and is expected to emerge as a major revenue generator by the year 2027. High concentration of research & academic institutes as well as biopharmaceutical companies are favoring the growth of North America market.
To access a sample copy or view this report in detail along with the table of contents, please click the link below:
Alternatively, Asia-Pacific cell line development market is estimated to exhibit the highest CAGR over 2020-2027, owing to flourishing healthcare sector in the region.
Global Cell Line Development Market Product Terrain (Revenue, USD Billion, 2017-2027)
Global Cell Line Development Market Type Sub-segments (Revenue, USD Billion, 2017-2027)
- Recombinant Cell Lines
- Primary Cell Lines
- Continuous Cell Lines
Global Cell Line Development Market Application Sub-segments (Revenue, USD Billion, 2017-2027)
- Drug Discovery
- Toxicity Testing
- Tissue Engineering & Regenerative Medicine
Global Cell Line Development Market Regional Analysis (Revenue, USD Billion, 2017-2027)
- South Korea
- Rest of Asia-Pacific
- United Kingdom
- Rest of Europe
Rest of the world
Global Cell Line Development Market Competitive Hierarchy (Revenue, USD Billion, 2017-2027)
- Sartorius AG
- WuXi AppTec Inc.
- Corning Incorporated
- European Collection of Authenticated Cell Cultures (ECACC)
- Selexis SA
- Sigma-Aldrich Corporation
- GE Healthcare
- Thermo Fisher Scientific Inc.
- Lonza Group AG
- American Type Culture Collection (ATCC)
Table of Content:
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2018-2027 (USD Billion)
1.2.1. Cell Line Development Market, by Region, 2018-2027 (USD Billion)
1.2.2. Cell Line Development Market, by Product, 2018-2027 (USD Billion)
1.2.3. Cell Line Development Market, by Type, 2018-2027 (USD Billion)
1.2.4. Cell Line Development Market, by Application, 2018-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Cell Line Development Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Cell Line Development Market Dynamics
3.1. Cell Line Development Market Impact Analysis (2018-2027)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Global Cell Line Development Market Industry Analysis
4.1. Porter’s 5 Force Model
4.2. PEST Analysis
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Cell Line Development Market, by Product
5.1. Market Snapshot
5.2. Global Cell Line Development Market by Product, Performance – Potential Analysis
5.3. Global Cell Line Development Market Estimates & Forecasts by Product 2017-2027 (USD Billion)
5.4. Cell Line Development Market, Sub Segment Analysis
Chapter 6. Global Cell Line Development Market, by Type
6.1. Market Snapshot
6.2. Global Cell Line Development Market by Type, Performance – Potential Analysis
6.3. Global Cell Line Development Market Estimates & Forecasts by Type 2017-2027 (USD Billion)
6.4. Cell Line Development Market, Sub Segment Analysis
6.4.1. Primary Cell Lines
6.4.2. Continuous Cell Lines
6.4.4. Recombinant Cell Lines
Chapter 7. Global Cell Line Development Market, by Application
7.1. Market Snapshot
7.2. Global Cell Line Development Market by Application, Performance – Potential Analysis
7.3. Global Cell Line Development Market Estimates & Forecasts by Application 2017-2027 (USD Billion)
7.4. Cell Line Development Market, Sub Segment Analysis
7.4.2. Tissue Engineering & Regenerative medicine
7.4.3. Toxicity Testing
7.4.5. Drug Discovery
Chapter 8. Global Cell Line Development Market, Regional Analysis
Cell Line Development Market Size, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2020 – 2026
Cell Line Development Market size to grow at around 12.5% CAGR between 2020 and 2026, as per new research report. The cell lines are used to study biological processes and retain stability of the formed tissues. These cell lines are used in production of vaccines, antibodies, artificial tissues and synthesis of biological components. Moreover, the cell lines play a crucial role in studying pathophysiological, physiological as well as differentiation process of specific cells. Cell line development market is also projected to record substantial proceeds from mammalian sources. Rapid technological advancements in cell line engineering can be credited as one of the key driving factors. The mammalian source segment was valued at more than USD 3 billion in 2019 and is further projected to stand as a lucrative avenue for market growth.
Market Study Report, LLC. is a hub for market intelligence products and services.
We streamline the purchase of your market research reports and services through a single integrated platform by bringing all the major publishers and their services at one place.
Our customers partner with Market Study Report, LLC. to ease their search and evaluation of market intelligence products and services and in turn focus on their company’s core activities.
If you are looking for research reports on global or regional markets, competitive information, emerging markets and trends or just looking to stay on top of the curve then Market Study Report, LLC. is the platform that can help you in achieving any of these objectives.
Contact Us: Corporate Sales, Market Study Report LLC Phone: 1-302-273-0910 Toll Free: 1-866-764-2150 Email: email@example.com News: https://www.newsorigins.com/